SHS Capital invests in healthcare companies with the ambition to become European champions. Leveraging over 30 years of sector expertise, a specialist network, and deep knowledge in market access, reimbursement, commercialization, M&A, and exits, SHS provides capital, strategic guidance, and synergies across its portfolio to drive value creation in fast-developing markets. Focused on DACH, Nordics, Benelux, and select other European regions, SHS targets companies with enterprise values up to €150M and equity tickets typically between €10M–€50M.
Bevorzugte Reifephase für die erste Finanzierung.
Established and growing healthcare companies, healthcare innovators in commercialization and scaling phases
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...